Accreditation Statistics

As of January 2, 2024

Cellular Therapy Entities

  • Accredited: 260
  • Applicants: 26

Cord Blood Banks

  • Accredited: 49
  • Applicants: 10

Congratulations to the following organizations for achieving initial FACT accreditation:

  • Houston Methodist Ann Kimball & John W. Johnson Center for Cellular Therapeutics
  • Blood Assurance
  • American National Red Cross, Salt Lake City, Utah HCT/P Program

A complete list of accredited organizations can be found at

Cord Blood Association Provides Listing of Peer Reviewed Articles Related to Dextran Shortages

Posted in :: 2021 Volume 5 :: Tuesday, October 26th, 2021

Current shortages of Dextran-40 in normal saline may have an impact on cellular therapy programs’ processes for preparing cord blood units for administration to patients. This shortage is expected to last until April 2022. To assist programs, the Cord Blood Association (CBA) provided some alternatives in a bulletin titled, Transplant Centers Report Dextran Shortage. The bulletin also includes a list of peer-reviewed articles published during a similar shortage in 2015. These articles are:

If your program uses Dextran-40 but switches to an alternative, the material must be qualified and validated or verified to produce expected results within your processes.